Nebula is free while in beta — browse the evidence map with no account.Open Nebula →

approval · primary record

SIBEPRENLIMAB-SZSI

FDA · BLA · 2025-11-25

AgencyFDA
Submission typeBLA
Action date2025-11-25
BrandVOYXACT
SponsorOTSUKA PHARM CO LTD
RouteINJECTION

Provenance

  • Source: openFDA Drugs@FDA
  • Fetched at: 2026-10-28T03:30:44.418Z
  • Licence class: public-domain
  • Verdict: primary-source
  • Entity id: FDA:SIBEPRENLIMAB-SZSI:2025-11-25

This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.

SIBEPRENLIMAB-SZSI — approval | AEaH